Drugs / High dose influenza vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02461758 | Oct 2016 → Jun 2018 | inflammatory bowel disease | University of Wisconsin, Madison | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | High dose influenza vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02461758 ↗ |
| Known as | HDIV | “High dose influenza vaccine (HDIV)” NCT02461758 ↗ |
| Modality | Vaccine | “high dose (HD) vs standard dose (SD) influenza vaccine” PMID 31504526 ↗ Mar 2020 |